The 340B Drug Pricing Program continues to evolve rapidly, with new manufacturer actions, rebate models, and regulatory changes reshaping how covered entities approach savings and program compliance. In this webinar, Stroudwater experts will review the fundamentals of 340B, discuss the differences between mixed-use and contract pharmacy models, and explore practical strategies to optimize capture rates and minimize exposure. We’ll also cover the value proposition of developing an in-house pharmacy, highlight major trends such as OP infusion, telehealth, and specialty pharmacy, and share insights on where the greatest growth opportunities lie for 2025 and beyond.
Key takeaways include:
- Understand the 340B basics: who qualifies, how savings are generated, and recent program developments.
- Differentiate models: learn the nuances of mixed-use versus contract pharmacy and where each can drive the most value.
- Optimize program performance: identify strategies to maximize capture rates through opportunity surveillance, alternative distribution, and minimizing WAC exposure.
- Evaluate in-house pharmacy opportunities: gain insights into the value proposition, development life cycle, and performance optimization.
- Anticipate trends: explore growth opportunities in outpatient infusion, telehealth, specialty pharmacy, and system partnerships.
- Get answers to your questions: engage in an interactive Q&A with Stroudwater’s 340B experts.
